Cargando…
A targeted controlled force injection of genetic material in vivo
A general limitation in gene delivery is the cellular uptake in lager animals including humans. Several approaches have been tested including liposomes, micro-needles, in vivo electro-transfer, ballistic delivery, and needle-free delivery. All these techniques have individual limitations. One approa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813609/ https://www.ncbi.nlm.nih.gov/pubmed/27069951 http://dx.doi.org/10.1038/mtm.2016.16 |
_version_ | 1782424303051997184 |
---|---|
author | Ahlén, Gustaf Frelin, Lars Holmström, Fredrik Smetham, Grant Augustyn, Steve Sällberg, Matti |
author_facet | Ahlén, Gustaf Frelin, Lars Holmström, Fredrik Smetham, Grant Augustyn, Steve Sällberg, Matti |
author_sort | Ahlén, Gustaf |
collection | PubMed |
description | A general limitation in gene delivery is the cellular uptake in lager animals including humans. Several approaches have been tested including liposomes, micro-needles, in vivo electro-transfer, ballistic delivery, and needle-free delivery. All these techniques have individual limitations. One approach reproducibly delivering genetic material in muscle tissue in nonhuman primates is hydrodynamic injection, a forced injection of a volume equaling the volume of the tissue to be transfected thereby causing an increased local pressure resulting in an improved uptake of genetic material. We transferred the principle of hydrodynamic injection to a device, where a small injection volume can be delivered to a targeted tissue volume, termed in vivo intracellular injection (IVIN). The device is based on needle(s) with apertures along the needle shafts, where multiple needles can fix the tissue volume to be transfected. The apertures direct the injection from a central needle outward or inward to the centroid of a geometric arrangement thereby targeting the tissue to be transfected. With a controlled force, this results in a targeted injection with increased transfection efficiency. We here show that the IVIN technology reproducibly improved plasmid uptake and expression and the immunogenicity. The IVIN technology can be generally applied to a targeted delivery of genetic materials. |
format | Online Article Text |
id | pubmed-4813609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48136092016-04-11 A targeted controlled force injection of genetic material in vivo Ahlén, Gustaf Frelin, Lars Holmström, Fredrik Smetham, Grant Augustyn, Steve Sällberg, Matti Mol Ther Methods Clin Dev Article A general limitation in gene delivery is the cellular uptake in lager animals including humans. Several approaches have been tested including liposomes, micro-needles, in vivo electro-transfer, ballistic delivery, and needle-free delivery. All these techniques have individual limitations. One approach reproducibly delivering genetic material in muscle tissue in nonhuman primates is hydrodynamic injection, a forced injection of a volume equaling the volume of the tissue to be transfected thereby causing an increased local pressure resulting in an improved uptake of genetic material. We transferred the principle of hydrodynamic injection to a device, where a small injection volume can be delivered to a targeted tissue volume, termed in vivo intracellular injection (IVIN). The device is based on needle(s) with apertures along the needle shafts, where multiple needles can fix the tissue volume to be transfected. The apertures direct the injection from a central needle outward or inward to the centroid of a geometric arrangement thereby targeting the tissue to be transfected. With a controlled force, this results in a targeted injection with increased transfection efficiency. We here show that the IVIN technology reproducibly improved plasmid uptake and expression and the immunogenicity. The IVIN technology can be generally applied to a targeted delivery of genetic materials. Nature Publishing Group 2016-03-30 /pmc/articles/PMC4813609/ /pubmed/27069951 http://dx.doi.org/10.1038/mtm.2016.16 Text en Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Ahlén, Gustaf Frelin, Lars Holmström, Fredrik Smetham, Grant Augustyn, Steve Sällberg, Matti A targeted controlled force injection of genetic material in vivo |
title | A targeted controlled force injection of genetic material in vivo |
title_full | A targeted controlled force injection of genetic material in vivo |
title_fullStr | A targeted controlled force injection of genetic material in vivo |
title_full_unstemmed | A targeted controlled force injection of genetic material in vivo |
title_short | A targeted controlled force injection of genetic material in vivo |
title_sort | targeted controlled force injection of genetic material in vivo |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813609/ https://www.ncbi.nlm.nih.gov/pubmed/27069951 http://dx.doi.org/10.1038/mtm.2016.16 |
work_keys_str_mv | AT ahlengustaf atargetedcontrolledforceinjectionofgeneticmaterialinvivo AT frelinlars atargetedcontrolledforceinjectionofgeneticmaterialinvivo AT holmstromfredrik atargetedcontrolledforceinjectionofgeneticmaterialinvivo AT smethamgrant atargetedcontrolledforceinjectionofgeneticmaterialinvivo AT augustynsteve atargetedcontrolledforceinjectionofgeneticmaterialinvivo AT sallbergmatti atargetedcontrolledforceinjectionofgeneticmaterialinvivo AT ahlengustaf targetedcontrolledforceinjectionofgeneticmaterialinvivo AT frelinlars targetedcontrolledforceinjectionofgeneticmaterialinvivo AT holmstromfredrik targetedcontrolledforceinjectionofgeneticmaterialinvivo AT smethamgrant targetedcontrolledforceinjectionofgeneticmaterialinvivo AT augustynsteve targetedcontrolledforceinjectionofgeneticmaterialinvivo AT sallbergmatti targetedcontrolledforceinjectionofgeneticmaterialinvivo |